i&i Prague

i&i Prague is a biotech incubator and venture builder focused on helping groundbreaking ideas in drug development, diagnostics, medical technologies, and other life sciences move from the lab to the market. They specialize in supporting startups in the early stages of development, providing expert consulting in scientific, legal, business, and other areas essential for successful growth. They aim to build a unique network of startups, investors, industrial partners, and biotechnology experts, enabling effective collaboration and knowledge sharing. Their incubation program offers step-by-step support in setting up a company, including market analysis and information, gaining early-on industry feedback, obtaining initial funding, and investor contacts. They seek to identify new inventions in Drug Discovery, Diagnostics, MedTech, and other Life Science fields, connecting innovation with capital and expertise to create growth opportunities. Their team leverages decades of know-how and experiences gathered in academic institutions, technology transfer, and industrial companies. i&i Prague's strategy involves actively sourcing biotech projects originating in academia and finding commercial partners for them. They acquire intellectual property rights from research institutions and collaborate with industrial partners for product development, manufacturing, and market entry. This collaborative approach allows them to bring scientific discoveries closer to real-world applications, as exemplified by their partnership with the Institute of Hematology and Blood Transfusion (ÚHKT) to commercialize an innovative liquid microextraction technology. Overall, i&i Prague aims to bridge the gap between academic research and commercialization by providing comprehensive support, facilitating collaborations, and leveraging their expertise in the biotech sector. They support scientific discoveries that can fundamentally improve patient care and believe in supporting scalable and beneficial technologies.

Drug development, diagnostics, medical technologies, life sciences

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.